Jennifer Jolly
Nurse Practitioner · Stevens Point, WINPI 1760820096
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,750 of the $11,226 with a category attached, or 77.9%. 27 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 29.3% of the total. Among nurse practitioner clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 182 payments — averaging $61.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$3K
- EMD Serono, Inc.$1K
- Novartis$902
- Biogen$865
- Teva Pharmaceuticals USA, Inc.$813
- TG Therapeutics, Inc.$498
- plus $4K from 21 others
What the payments were for
- Travel & lodging$1,99518%
- Food & beverage$8,75078%
- Education$4804%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 46 | $3,291 |
| EMD Serono, Inc. | 13 | $1,292 |
| Novartis | 24 | $902 |
| Biogen | 12 | $865 |
| Teva Pharmaceuticals USA, Inc. | 12 | $813 |
| TG Therapeutics, Inc. | 4 | $498 |
| Pfizer | 9 | $435 |
| AbbVie | 8 | $416 |
| Harmony Biosciences LLC | 12 | $384 |
| E.r. Squibb & Sons, L.L.C. | 3 | $294 |
| Neurelis, Inc. | 3 | $271 |
| AstraZeneca | 4 | $264 |
| Eisai Inc. | 5 | $242 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $186 |
| Jazz Pharmaceuticals Inc. | 5 | $160 |
| Lilly USA, LLC | 6 | $133 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $125 |
| SK Life Science, Inc. | 1 | $125 |
| UCB, Inc. | 1 | $125 |
| Corium, LLC | 2 | $106 |
| Johnson & Johnson | 1 | $98 |
| Bristol Myers Squibb | 3 | $68 |
| Biohaven Pharmaceuticals, Inc. | 1 | $58 |
| Medtronic | 1 | $21 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $19 |
| Sandoz | 1 | $18 |
| Neurocrine Biosciences, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,226 in reported general payments places this provider in the 95th percentile of 3,478 nurse practitioner providers in Wisconsin.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Kesimpta PenOfatumumab | 23 | $230,536 |
| Avonex (4 Pack)Interferon Beta-1a | 13 | $102,973 |
| CopaxoneGlatiramer Acetate | 11 | $62,869 |
| Emgality PenGalcanezumab-Gnlm | 63 | $54,832 |
| Dimethyl Fumarate | 22 | $43,937 |
| UbrelvyUbrogepant | 29 | $30,129 |
| Nurtec OdtRimegepant Sulfate | 19 | $25,997 |
| LamictalLamotrigine | 11 | $21,292 |
| Ajovy AutoinjectorFremanezumab-Vfrm | 19 | $17,958 |
| Aimovig AutoinjectorErenumab-Aooe | 19 | $15,506 |
| Dalfampridine ErDalfampridine | 21 | $8,729 |
| Pregabalin | 95 | $4,344 |
| Mirtazapine | 135 | $3,528 |
| Memantine Hcl | 182 | $3,298 |
| Gabapentin | 125 | $3,226 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| BiogenAvonex (4 Pack) | $865 | $102,97313 claims |
| Teva Pharmaceuticals USA, Inc.Copaxone | $813 | $62,86911 claims |
| AbbVieUbrelvy | $416 | $30,12929 claims |
| PfizerNurtec Odt | $435 | $25,99719 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,478 nurse practitioner providers in Wisconsin.
Other nurse practitioner in Stevens Point
- Jodi StrongStevens Point$246K
- Jo Ellen FrawleyPrairie du Sac$194K
- Trisha WilcoxMilwaukee$174K
- Sally BowaGreen Bay$117K
- Christina SauldMilwaukee$111K
- Melissa WendellWausau$98K
- Nicole BarteltWaukesha$85K
- Kari FisherPrairie du Sac$57K
- Roxanne RadichAppleton$54K
- Kelly FlugaurMilwaukee$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.